Cargando…
Comparison of the Effect of Alemtuzumab versus Standard Immune Induction on Early Kidney Allograft Function in Shiraz Transplant Center
BACKGROUND: Induction therapy regimens classified as conventional immunosuppressive agents and lower doses of conventional agents combined with antibodies against T-cell antigens have been purposed to prevent acute rejection after renal transplantation. Various induction agents with different doses...
Autores principales: | Khalafi-Nezhad, A., Sagheb, M. M., Amirmoezi, F., Jowkar, Z., Dehghanian, A. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Avicenna Organ Transplantation Institute
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644567/ https://www.ncbi.nlm.nih.gov/pubmed/26576260 |
Ejemplares similares
-
Alemtuzumab induction in pediatric kidney transplantation
por: Kaabak, Michael M, et al.
Publicado: (2013) -
Association between TLR2 and TLR4 Expression and Response to Induction Therapy in Acute Myeloid Leukemia Patients
por: Ramzi, Mani, et al.
Publicado: (2018) -
Pulse Oximeter Oxygen Saturation in Prediction of Arterial Oxygen Saturation in Liver Transplant Candidates
por: Ghayumi, Seiyed Mohammad Ali, et al.
Publicado: (2014) -
Alemtuzumab induction therapy in solid organ transplantation
por: Friend, Peter J
Publicado: (2013) -
Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience
por: Furukawa, Masashi, et al.
Publicado: (2022)